Urology · Fullerton, CA
NPI
1508936592
Since 2006
Specialty
Urology
Code 208800000X
Group practices
7
Medicare group memberships
Hospitals
5
Hospital affiliations
1950 Sunnycrest Dr, #3400
Fullerton, CA, 92835
Phone (714) 879-2410
Groups this clinician bills Medicare through
Medicare paid, 2024
$266K
2,301 services
Medicare patients, 2024
550
Average age 77
Drug cost, 2024
$421K
6,194 prescriptions
Company payments, 2025
$2,522
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ali S Alavi was code 81002 (clinical chemistry), 637 times for 421 patients. In total Ali S Alavi billed 2,301 services in 55 codes, and Medicare paid $266K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81002 Clinical Chemistry | Office | 637 | 421 | $3.41 | $2,172 |
| 99214 Office E&M - Established | Office | 631 | 419 | $103.16 | $65K |
| 51798 Ultrasound - Nonspecific | Office | 301 | 229 | $9.90 | $2,979 |
| 52442 Cystourethroscopy | Office | 108 | 20 | $854.75 | $92K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 104 | 100 | $92.39 | $9,609 |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 103 | 99 | $58.11 | $5,986 |
| 99204 Office E&M - New | Office | 79 | 79 | $141.26 | $11K |
| 99213 Office E&M - Established | Office | 53 | 53 | $49.46 | $2,621 |
| 52000 Cystourethroscopy | Office | 37 | 34 | $209.91 | $7,767 |
| 52441 Cystourethroscopy | Office | 20 | 20 | $1,172.52 | $23K |
| 99223 Hospital E&M - Initial | Facility | 17 | 16 | $153.32 | $2,606 |
| 51741 Test - Miscellaneous | Office | 11 | 11 | $10.89 | $120 |
By year: 2022 $487K for 4,980 services; 2023 $339K for 3,525 services; 2024 $266K for 2,301 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 637 | 421 | $3.41 | $2,172 |
Medicare prescription drug claims, 2024
In 2024, the drug Ali S Alavi prescribed most often to Medicare patients was Finasteride, with 1,816 prescriptions and refills. In total Ali S Alavi wrote 6,194 Medicare prescriptions that cost $421K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Finasteride Generic | 1,816 | 5,169 | 589 | $26K |
| Tamsulosin Hcl Generic | 1,759 | 5,003 | 586 | $33K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 318 | 780 | 109 | $6,813 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 315 | 900 | 108 | $7,253 |
| Dutasteride Generic | 147 | 423 | 44 | $3,949 |
| Methenamine Hippurate Generic | 133 | 329 | 50 | $11K |
| Myrbetriq Mirabegron | 117 | 253 | 38 | $113K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 114 | 120 | 76 | $2,304 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 100 | 106 | 76 | $307 |
| Silodosin Generic | 97 | 240 | 30 | $8,355 |
| Bicalutamide Generic | 87 | 101 | 62 | $1,559 |
| Gemtesa Vibegron | 82 | 170 | 22 | $79K |
| Doxazosin Mesylate Generic | 80 | 239 | 29 | $1,582 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 72 | 72 | 62 | $299 |
| Estradiol Generic | 67 | 189 | 37 | $4,619 |
Brand drugs: - claims; generic drugs: 5,926 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ali S Alavi $2,522 ($2,522 in general payments such as food, travel and fees) from 18 companies. The largest payer was Teleflex LLC with $728.
| Company | Payments | Amount |
|---|---|---|
| Teleflex LLC TFX | 7 | $728 |
| Boston Scientific Corporation BSX | 4 | $315 |
| Urogen Pharma, Inc. URGN | 12 | $293 |
| Medtronic, Inc. MDT | 9 | $175 |
| Coloplast Corp | 3 | $172 |
| Procept Biorobotics Corporation PRCT | 2 | $170 |
| Sumitomo Pharma America, Inc. 4506.T | 7 | $158 |
| Abbvie Inc. ABBV | 6 | $126 |
| Astellas Pharma US Inc 4503.T | 2 | $105 |
| Pfizer Inc. PFE | 3 | $74.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.